These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 2890779

  • 21. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G, Alloatti G, Mariano F, Lupia E, Lucchina PG, Musso E, Emanuelli G, Camussi G.
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [Abstract] [Full Text] [Related]

  • 22. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z, Imura Y, Takatani M, Tsushima S, Nishikawa K.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [Abstract] [Full Text] [Related]

  • 23. Comparison of three paf-acether receptor antagonist ginkgolides.
    Korth R, Nunez D, Bidault J, Benveniste J.
    Eur J Pharmacol; 1988 Jul 26; 152(1-2):101-10. PubMed ID: 2850196
    [Abstract] [Full Text] [Related]

  • 24. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X.
    Int J Tissue React; 1985 Jul 26; 7(5):339-43. PubMed ID: 2997065
    [Abstract] [Full Text] [Related]

  • 25. Competitive inhibition of tritium-labeled platelet-activating factor binding to rabbit platelet membranes by amiloride and amiloride analogs.
    Hwang SB.
    Biochem Biophys Res Commun; 1989 Aug 30; 163(1):165-71. PubMed ID: 2549986
    [Abstract] [Full Text] [Related]

  • 26. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
    Castro-Faria-Neto HC, Bozza PT, Cruz HN, Silva CL, Violante FA, Barbosa-Filho JM, Thomas G, Martins MA, Tibiriçá EV, Noel F.
    Planta Med; 1995 Apr 30; 61(2):101-5. PubMed ID: 7753913
    [Abstract] [Full Text] [Related]

  • 27. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.
    Hwang SB.
    J Biol Chem; 1988 Mar 05; 263(7):3225-33. PubMed ID: 2830276
    [Abstract] [Full Text] [Related]

  • 28. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L, Floch A, Cavero I.
    J Pharmacol Exp Ther; 1990 Mar 05; 252(3):1221-7. PubMed ID: 2156995
    [Abstract] [Full Text] [Related]

  • 29. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
    Ko FN, Yu SM, Chen IS, Ishii H, Chang YL, Huang TF, Teng CM.
    Biochim Biophys Acta; 1993 Jan 17; 1175(2):225-31. PubMed ID: 8380343
    [Abstract] [Full Text] [Related]

  • 30. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ, Yaremko B, Selig WM, Janero DR, Burghardt C, Welton AF, O'Donnell M.
    J Pharmacol Exp Ther; 1991 Oct 17; 259(1):78-85. PubMed ID: 1656030
    [Abstract] [Full Text] [Related]

  • 31. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N, Etienne A, Braquet P.
    Agents Actions Suppl; 1986 Oct 17; 20():87-97. PubMed ID: 3028108
    [Abstract] [Full Text] [Related]

  • 32. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
    Lee CM, Jiang LM, Shang HS, Hon PM, He Y, Wong HN.
    Br J Pharmacol; 1991 Jul 17; 103(3):1719-24. PubMed ID: 1657264
    [Abstract] [Full Text] [Related]

  • 33. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M, Tomomatsu N, Iwahisa Y, Yamaguchi S, Kawakami Y, Terasawa M.
    Pharmacology; 1997 May 17; 54(5):261-70. PubMed ID: 9380772
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
    Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2749-52. PubMed ID: 2820421
    [Abstract] [Full Text] [Related]

  • 35. Bakkenolide G, a natural PAF-receptor antagonist.
    Liao CH, Ko FN, Wu TS, Teng CM.
    J Pharm Pharmacol; 1997 Dec 01; 49(12):1248-53. PubMed ID: 9466352
    [Abstract] [Full Text] [Related]

  • 36. Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes.
    Herbert JM, Laplace MC, Maffrand JP.
    Biochem Pharmacol; 1993 Jan 07; 45(1):51-8. PubMed ID: 8381007
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes.
    Aratani H, Nishida Y, Terasawa M, Maruyama Y.
    Jpn J Pharmacol; 1988 Jun 07; 47(2):200-3. PubMed ID: 2848961
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.